Any clinical discussion on medical cannabis is limited by the relative paucity of randomized controlled trials. Only a small number of clinical studies involving the therapeutic use of cannabis have been carried out to date. And, of those studies, only short term adverse effects associated with cannabis use have been evaluated. In general, the medical…
Read More »Doctors with the U.S. Department of Veterans Affairs still can’t recommend medical marijuana, but they are being encouraged to talk more about it with military veterans.
Read More »https://www.ncbi.nlm.nih.gov/pubmed/17185040 Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune system, respectively, and mediate a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind CB1 are also psychoactive thereby limiting their clinical use. In this study, we investigated the immunosuppressive properties of JWH-015, a synthetic CB2-selective…
Read More »“Medical marijuana is here to stay. With medical marijuana being new to many states, there are more questions than answers about how it will affect our communities. Each state with medical marijuana laws may address important issues related to the laws differently. Many of our colleagues see medical marijuana as an unwanted problem in our…
Read More »